GlaxoSmithKline Plc - Strategy, SWOT, and Corporate Finance Report

The GlaxoSmithKline Plc’s SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, detailed financials, and corporate actions, providing a 360° view of the company.

Scope:

- Provides detailed information on GlaxoSmithKline Plc required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting GlaxoSmithKline Plc in the form of a SWOT analysis
- Offers an in-depth view of the business model of GlaxoSmithKline Plc including a breakdown and examination of key business segments
- Contains five-year financial information and charts, including balance sheet, income statement, cash flows, market capitalization and multiples, and key ratios for GlaxoSmithKline Plc
- Provides intelligence on GlaxoSmithKline Plc’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- Captures the latest news about GlaxoSmithKline Plc, such as business expansion, restructuring, and contract wins
- Includes large number of easy-to-grasp charts and graphs that present important data and key trends

Highlights:

This report includes GlaxoSmithKline Plc's business description, segment overview, company history, products and services, SWOT analysis, 5-year financial statements and ratios, management statement, key executives and biographies, key competitors, locations and subsidiaries, contact information, latest news, and corporate activity including M&A, private equity, venture financing, public offerings, private placements and partnerships, and a list of legal and financial advisors.

Reasons to Purchase:

- Gain understanding of the company and the factors that influence its strategies
- Track strategic initiatives of the company and latest corporate news and actions
- Assess prospective partners, vendors and suppliers
- Support sales activities by understanding your customers' businesses better
- Stay up to date on your competitors' business structure, strategy and prospects SHOW LESS READ MORE >

Company Snapshot
GlaxoSmithKline Plc: Company Overview
GlaxoSmithKline Plc: Overview and Key Facts
GlaxoSmithKline Plc: Overview
GlaxoSmithKline Plc: Key Facts
GlaxoSmithKline Plc: Key Employees
GlaxoSmithKline Plc: Key Employee Biographies
GlaxoSmithKline Plc: Major Products and Services
GlaxoSmithKline Plc: Company History
GlaxoSmithKline Plc: Management Statement
GlaxoSmithKline Plc: Locations and Subsidiaries
GlaxoSmithKline Plc: Key Competitors
GlaxoSmithKline Plc: Company Analysis
GlaxoSmithKline Plc: Business Description
GlaxoSmithKline Plc: SWOT Analysis
GlaxoSmithKline Plc: SWOT Overview
GlaxoSmithKline Plc: Strengths
GlaxoSmithKline Plc: Weaknesses
GlaxoSmithKline Plc: Opportunities
GlaxoSmithKline Plc: Threats
GlaxoSmithKline Plc: Financial Analysis
GlaxoSmithKline Plc: Financial Overview
GlaxoSmithKline Plc: Five Year Company Financials
GlaxoSmithKline Plc: Key Income Statement Data
GlaxoSmithKline Plc: Key Balance Sheet Data
GlaxoSmithKline Plc: Key Cash Flow Data
GlaxoSmithKline Plc: Key Market Data
GlaxoSmithKline Plc: Valuation Ratios
GlaxoSmithKline Plc: Profitability Ratios
GlaxoSmithKline Plc: Management Efficiency Ratios
GlaxoSmithKline Plc: Financial Strength Ratios
GlaxoSmithKline Plc: Operational Efficiency Ratios
GlaxoSmithKline Plc: Others
GlaxoSmithKline Plc: Corporate Financial Deals Activity
GlaxoSmithKline Plc: Financial Deals Overview
GlaxoSmithKline Plc: Targets and Partners
GlaxoSmithKline Plc: Top Deals 2007 -YTD-
GlaxoSmithKline Plc: Advisors
GlaxoSmithKline Plc: Top Legal Advisors
GlaxoSmithKline Plc: Top Financial Advisors
GlaxoSmithKline Plc: Mergers and Acquisitions
GlaxoSmithKline Plc: Corporate Venturing
GlaxoSmithKline Plc: Partnership
GlaxoSmithKline Plc: Divestments
GlaxoSmithKline Plc: Private Equity and Ownership
GlaxoSmithKline Plc: Recent Developments
GlaxoSmithKline Plc: News and Events Summary
GlaxoSmithKline Plc: Contracts
GlaxoSmithKline Plc: Financial Deals
GlaxoSmithKline Plc: Regulatory and Legal Events
GlaxoSmithKline Plc: Research & Development
GlaxoSmithKline Plc: Strategy and Operations
Appendix
Contact Us
Methodology
Definitions
About Datamonitor

List of Tables

Table 1: GlaxoSmithKline Plc: Key Facts
Table 2: GlaxoSmithKline Plc: Key Employees
Table 4: GlaxoSmithKline Plc: Key Competitors
Table 5: GlaxoSmithKline Plc: Key Income Statement Data
Table 6: GlaxoSmithKline Plc: Key Balance Sheet Data
Table 7: GlaxoSmithKline Plc: Key Cash Flow Data
Table 8: GlaxoSmithKline Plc: Key Market Data
Table 9: GlaxoSmithKline Plc: Key Growth Ratios
Table 10: GlaxoSmithKline Plc: Valuation Ratios
Table 11: GlaxoSmithKline Plc: Profitability Ratios
Table 12: GlaxoSmithKline Plc: Management Efficiency Ratios
Table 13: GlaxoSmithKline Plc: Financial Strength Ratios
Table 14: GlaxoSmithKline Plc: Operational Efficiency Ratios
Table 15: GlaxoSmithKline Plc: Others
Table 16: GlaxoSmithKline Plc: Deal Activity by Deal Type - Volume (TTM)
Table 17: GlaxoSmithKline Plc: M&A Activity by Geography (TTM)
Table 18: GlaxoSmithKline Plc: Deal Activity by Deal Type - Volume (2007 - YTD-2011)
Table 19: GlaxoSmithKline Plc: M&A Average Deal Size - Value (US$m)
Table 20: GlaxoSmithKline Plc: Targets and Partners
Table 21: GlaxoSmithKline Plc: Top Deals 2007 -YTD-
Table 22: GlaxoSmithKline Plc: Legal Advisor Ranking by Value (US$m)
Table 23: GlaxoSmithKline Plc: Financial Advisor Ranking by Value (US$m)
Table 24: GlaxoSmithKline Plc: M&A Volume and Value Trend (2007 - YTD-2011)
Table 25: GlaxoSmithKline Plc: M&A Activity by Geography (2007 - YTD-2011)
Table 26: GlaxoSmithKline Plc: Corporate Venturing Volume and Value Trend (2007 - YTD-2011)
Table 27: GlaxoSmithKline Plc: Corporate Venturing by Geography (2007 - YTD-2011)
Table 28: GlaxoSmithKline Plc: Partnership Volume and Value Trend (2007 - YTD-2011)
Table 29: GlaxoSmithKline Plc: Partnership Trend by Deal Type (2007 - YTD-2011)
Table 30: GlaxoSmithKline Plc: Divestments Volume and Value Trend (2007 - YTD-2011)
Table 31: GlaxoSmithKline Plc: Divestments by Geography (2007 - YTD-2011)
Table 32: GlaxoSmithKline Plc: Private Equity and Ownership Volume and Value Trend (2007 - YTD-2011)
Table 33: GlaxoSmithKline Plc: Private Equity and Ownership Volume by Deal Type (2007 - YTD-2011)
Table 34: GlaxoSmithKline Plc: News and Events Summary
Table 35: GlaxoSmithKline Plc: Contracts
Table 36: GlaxoSmithKline Plc: Financial Deals
Table 37: GlaxoSmithKline Plc: Regulatory and Legal Events
Table 38: GlaxoSmithKline Plc: Research & Development
Table 39: GlaxoSmithKline Plc: Strategy and Operations

List of Figures

Figure 1: GlaxoSmithKline Plc: Revenue to Net Income (2005-2009)
Figure 2: GlaxoSmithKline Plc: Revenue/Employee to Net Income/Employee (2005-2009)
Figure 3: GlaxoSmithKline Plc: Current Assets to Current Liabilities (2005-2009)
Figure 4: GlaxoSmithKline Plc: Assets, Liabilities to Total Equity (2005-2009)
Figure 5: GlaxoSmithKline Plc: Free Cash Flow to Cash from Operating Activities (2005-2009)
Figure 6: GlaxoSmithKline Plc: Net Change in Cash (2005-2009)
Figure 7: GlaxoSmithKline Plc: Market Capitalization to Year-end Share Price (2005-2009)
Figure 8: GlaxoSmithKline Plc: Enterprise Value (2005-2009)
Figure 9: GlaxoSmithKline Plc: Deal Activity by Deal Type - Volume (TTM)
Figure 10: GlaxoSmithKline Plc: M&A Activity by Geography (TTM)
Figure 11: GlaxoSmithKline Plc: Deal Activity by Deal Type - Volume (2007 - YTD-2011)
Figure 12: GlaxoSmithKline Plc: M&A Average Deal Size - Value (US$m)
Figure 13: GlaxoSmithKline Plc: M&A Volume and Value Trend (2007 - YTD-2011)
Figure 14: GlaxoSmithKline Plc: M&A Activity by Geography (2007 - YTD-2011)
Figure 15: GlaxoSmithKline Plc: Corporate Venturing Volume and Value Trend (2007 - YTD-2011)
Figure 16: GlaxoSmithKline Plc: Corporate Venturing by Geography (2007 - YTD-2011)
Figure 17: GlaxoSmithKline Plc: Partnership Volume and Value Trend (2007 - YTD-2011)
Figure 18: GlaxoSmithKline Plc: Partnership Trend by Deal Type (2007 - YTD-2011)
Figure 19: GlaxoSmithKline Plc: Divestments Volume and Value Trend (2007 - YTD-2011)
Figure 20: GlaxoSmithKline Plc: Divestments by Geography (2007 - YTD-2011)
Figure 21: GlaxoSmithKline Plc: Private Equity and Ownership Volume and Value Trend (2007 - YTD-2011)
Figure 22: GlaxoSmithKline Plc: Private Equity and Ownership Volume by Deal Type (2007 - YTD-2011)